Top compounds associated with response to RP11-201K10.3


Feature Type Standardized
Nominal ANOVA
mRNA niclosamide CTRPv2 pan-cancer AAC 0.012 0.7
mRNA erlotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.013 0.7
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.012 0.7
mRNA pac-1 CTRPv2 pan-cancer AAC -0.012 0.7
mRNA ML312 CTRPv2 pan-cancer AAC 0.024 0.7
mRNA BRD-K04800985 CTRPv2 pan-cancer AAC 0.013 0.7
mRNA Vandetanib CTRPv2 pan-cancer AAC -0.012 0.7
mRNA BRD-K44224150 CTRPv2 pan-cancer AAC 0.025 0.7
mRNA PX-12 CTRPv2 pan-cancer AAC 0.0093 0.7
mRNA VX-680 CTRPv2 pan-cancer AAC 0.033 0.7
Download CSV